MedTrace Logo

Single and Multiple Dose Evaluation of QBKPN SSI In Healthy Volunteers

NCT02897999 · Status: WITHDRAWN · Phase: PHASE1 · Type: INTERVENTIONAL

Last updated 2017-08-24

No results posted yet for this study

Summary

The purpose of this dose-escalation study is to assess the safety and pharmacodynamics of single and multiple doses of QBKPN SSI, administered subcutaneously to healthy adult volunteers

Conditions

  • Healthy

Interventions

BIOLOGICAL

QBKPN

QBKPN Site Specific Immunomodulators

OTHER

Placebo

Placebo

Sponsors & Collaborators

  • Qu Biologics Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2017-02-28
Completion
2017-02-28

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02897999 on ClinicalTrials.gov